Titan Bio-Tech (TITANBIO) | Stock Overview & Key Data
Titan Bio-Tech Performance Comparison
Stock Range
Today's Range
Low: ₹946.00
High: ₹975.00
on October 3, 2025
52 Week Range
Low: ₹373.65
High: ₹1,017.00
on June 19, 2025
on September 23, 2025
All-Time High: ₹1,017.85 on October 21, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR8.1B
EPS
26.62
P/E Ratio (TTM)
35.79
Forward P/E
N/A
P/B Ratio
5.13
PEG Ratio
4.99
Div. Yield
0.42%
ROE
14.04%
Beta
0.231
Debt to Equity
1.82
Financial Highlights
Profitability
Gross Margin
48.49%
Operating Margin
16.31%
Profit Margin
13.76%
Returns and Earnings
Return on Assets (TTM)
12.32%
Return on Equity (TTM)
14.04%
EBITDA
INR291.5M
Net Income (TTM)
INR219.9M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR193.42
Quarterly Revenue Growth (YoY)
7.80%
Quarterly Earnings Growth (YoY)
7.20%
Dividend Information
Last 12-Month Dividend
₹4.00
Current Dividend Yield
0.42%
3-Year Average Dividend Yield
0.34%
3-Year Average Annual Dividend
₹1.93
3-Year Total Dividends
₹5.80
Ex-Dividend Date
September 19, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Titan Bio-Tech TITANBIO | 8.10B Small-cap | 7.36% | 37.60% | 123.15% | 104.11% | 26.96% | 33.04% | 252.87% | 522.82% |
| Biocon BIOCON | 470.24B Large-cap | 3.94% | -2.57% | -5.93% | 1.88% | -4.49% | 1.70% | 24.54% | -22.05% |
| OneSource Specialty ONESOURCE | 212.56B Large-cap | 0.90% | -4.90% | -9.68% | 14.74% | 5.61% | 5.61% | 5.61% | 5.61% |
| Zota Health Care ZOTA | 45.32B Small-cap | -4.00% | 16.56% | 44.43% | 72.88% | 76.58% | 137.77% | 382.52% | 863.38% |
| Dishman Carbogen DCAL | 45.33B Small-cap | 1.33% | 6.52% | 11.35% | 26.46% | -0.11% | 62.68% | 168.99% | 66.89% |
| Panacea Biotec PANACEABIO | 25.45B Small-cap | -0.04% | -2.22% | -4.62% | -10.01% | -7.42% | 32.45% | 205.48% | 115.98% |
Ownership & Short Interest
Insider Ownership
66.78%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
31K
Average 90-Day Volume
32K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is TITANBIO's 52-week high and low?
- In the last 52 weeks, Titan Bio-Tech reached a high of ₹1,017.00 (on September 23, 2025) and a low of ₹373.65 (on June 19, 2025).
- What is the market cap and P/E ratio for TITANBIO?
- Curious about Titan Bio-Tech's size and valuation? Its market capitalization stands at 8.10B. When it comes to valuation, the P/E ratio (trailing twelve months) is 35.79, and the forward P/E (looking ahead) is N/A.
- Does TITANBIO pay dividends? If so, what's the yield?
- Yes, Titan Bio-Tech is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.42%, and the company has paid an average of ₹1.93 per share annually over the past 3 years.
- Who are Titan Bio-Tech's main competitors or similar companies to consider before investing?
When looking at Titan Bio-Tech, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Biocon
BIOCON470.24B Healthcare Biotechnology 1.70% 24.54% OneSource Specialty
ONESOURCE212.56B Healthcare Biotechnology 5.61% 5.61% Zota Health Care
ZOTA45.32B Healthcare Biotechnology 137.77% 382.52% Dishman Carbogen
DCAL45.33B Healthcare Biotechnology 62.68% 168.99% Panacea Biotec
PANACEABIO25.45B Healthcare Biotechnology 32.45% 205.48% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Titan Bio-Tech Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Titan Bio-Tech's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 14.04%, the Debt to Equity ratio from the most recent quarter is 1.82, and its Gross Profit Margin stands at 48.49%.
- What is the recent revenue and earnings growth for TITANBIO?
- Looking at Titan Bio-Tech's growth, its revenue over the trailing twelve months (TTM) was INR2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 7.80%, and quarterly earnings saw a YoY growth of 7.20%.
- How much of TITANBIO stock is held by insiders and institutions?
- Wondering who owns Titan Bio-Tech stock? Company insiders (like executives and directors) hold about 66.78% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.